Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Obes Surg ; 27(3): 657-664, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27525641

RESUMEN

BACKGROUND: This study aimed to investigate the influence of new biliopancreatic diversion (NBPD) and duodenal-jejunal bypass (DJB) surgery on blood glucose, lipids, gastrointestinal hormones, and insulin in Goto-Kakizaki (GK) rats, an animal model for type 2 diabetes, in order to elucidate the mechanisms underlying the therapeutic effect of these types of surgery on this clinical condition. METHODS: Thirty 30 male GK rats (SPF) aged 12 weeks were randomly assigned into three groups (n = 10 per group): sham group, NBPD group, and DJB group. Body weight, random plasma glucose, fasting plasma glucose (FPG), oral glucose tolerance (OGT), blood lipids, plasma insulin, glucagon like peptide-1 (GLP-1), and gastric inhibitory polypeptide (GIP) were measured before and after surgery. RESULTS: NBPD surgery improved glucose tolerance, decreased fasting free fatty acids, triglycerides, and cholesterol. It also increased fasting and postprandial GIP, but caused no change in GLP-1. DJB surgery produced results similar to NBPD surgery except for causing a decrease in postprandial GLP-1 and insulin, and a larger increase in fasting GIP. CONCLUSIONS: Moving the biliopancreatic duct outlet to the mid-jejunum (NBPD surgery) improves glucose tolerance and increases GIP, but does not change GLP-1. Adding duodenal bypass (DJB surgery) increases fasting GIP and decreases postprandial GLP-1.


Asunto(s)
Desviación Biliopancreática/métodos , Glucemia/metabolismo , Diabetes Mellitus Experimental/cirugía , Diabetes Mellitus Tipo 2/cirugía , Lípidos/sangre , Animales , Glucemia/análisis , Diabetes Mellitus Experimental/sangre , Duodeno/cirugía , Derivación Gástrica/métodos , Polipéptido Inhibidor Gástrico/sangre , Péptido 1 Similar al Glucagón/sangre , Prueba de Tolerancia a la Glucosa , Insulina/sangre , Resistencia a la Insulina , Yeyuno/cirugía , Metabolismo de los Lípidos/fisiología , Masculino , Ratas
2.
Obes Surg ; 23(4): 522-30, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23207830

RESUMEN

BACKGROUND: The purpose of this study was to investigate the hypoglycemic effect of new biliopancreatic diversion and duodenal-jejunal bypass in Goto-Kakizaki rats and observe effects of the new surgical procedure on the glucose tolerance of GK rats. METHODS: Twenty-four 10-week-old rats (SPF grade) were randomly divided into groups A, B, and C, each with eight rats. Group A underwent duodenal-jejunal bypass, group B underwent modified biliopancreatic diversion, and group C underwent a sham operation. Median rat body weight, fasting blood glucose, OGTT, and blood lipids were measured in fasting 1 week before surgery and 1, 2, 4, and 8 weeks after surgery. Changes in gastric inhibitory polypeptide, glucagon P-like peptide-1, and insulin levels were measured by ELISA 1 week before surgery and 8 weeks after surgery. RESULTS: Rats' mean body weight in groups A and B decreased significantly from 368.025 ± 11.726 and 373.100 ± 9.859 g preoperatively to 345.750 ± 11.403 and 343.260 ± 12.399 g at the early postoperative stage (P < 0.05), and with statistically significant differences compared to the weight of rats in group C (P < 0.05). Comparisons between fasting blood glucose before surgery and 8 weeks after surgery revealed no significant differences between all three groups (P > 0.05). Glucose tolerance in groups A and B decreased from preoperative 21.175 ± 3.684 and 20.820 ± 1.671 mmol/L to postoperative 8.950 ± 0.580 and 10.500 ± 1.509 mmol/L, and both were better than that of group C (P < 0.001). CONCLUSIONS: Both new biliopancreatic diversion and duodenal-jejunal bypass improve glucose tolerance of Goto-Kakizaki rats.


Asunto(s)
Desviación Biliopancreática/métodos , Diabetes Mellitus Experimental/cirugía , Duodeno/cirugía , Prueba de Tolerancia a la Glucosa , Yeyuno/cirugía , Animales , Glucemia/metabolismo , Peso Corporal , Diabetes Mellitus Experimental/sangre , Polipéptido Inhibidor Gástrico/sangre , Péptido 1 Similar al Glucagón/sangre , Insulina/sangre , Lípidos/sangre , Masculino , Distribución Aleatoria , Ratas , Ratas Endogámicas
3.
Lin Chuang Er Bi Yan Hou Ke Za Zhi ; 20(8): 360-1, 2006 Apr.
Artículo en Chino | MEDLINE | ID: mdl-16838744

RESUMEN

OBJECTIVE: To observe and summarize the clinical effect of nasal septum surgery combined with multi-sinus surgery and to discuss the safety and feasibility. METHOD: Fifty-six patients with nasal sinuses and nasal cavity diseases received nasal septal reconstruction, Caldwell-Lue procedure, polypectomy, ethmoidectomy and partial middle or inferior turbinate resection simultaneously under local anesthesia, and the complications after surgery were observed. RESULT: Operation in fifty-six patients were completed successfully. Thirty cases were cured, the cure rate of 56 case was 53.57Y, 23 cases were effective recovered (41.07%), 3 cases didn't recover (5.36%). The clinical cure rate was 94.64%. No severe complications occurred. CONCLUSION: The nasal septal surgery combined with multi-sinus surgery simultaneously under local anesthesia is effective and safety procedure. It can decrease the recurrence rate of nasal polyp and sinusitis and don't increase the rate of complication occurring.


Asunto(s)
Pólipos Nasales/cirugía , Tabique Nasal/cirugía , Sinusitis/cirugía , Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Otorrinolaringológicos , Resultado del Tratamiento , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA